Mena-Vázquez, N.; Rojas-Gimenez, M.; Fuego-Varela, C.; GarcÃa-Studer, A.; Perez-Gómez, N.; Romero-Barco, C.M.; Godoy-Navarrete, F.J.; Manrique-Arija, S.; GandÃa-MartÃnez, M.; Calvo-Gutiérrez, J.;
et al. Safety and Effectiveness of Abatacept in a Prospective Cohort of Patients with Rheumatoid Arthritis–Associated Interstitial Lung Disease. Biomedicines 2022, 10, 1480.
https://doi.org/10.3390/biomedicines10071480
AMA Style
Mena-Vázquez N, Rojas-Gimenez M, Fuego-Varela C, GarcÃa-Studer A, Perez-Gómez N, Romero-Barco CM, Godoy-Navarrete FJ, Manrique-Arija S, GandÃa-MartÃnez M, Calvo-Gutiérrez J,
et al. Safety and Effectiveness of Abatacept in a Prospective Cohort of Patients with Rheumatoid Arthritis–Associated Interstitial Lung Disease. Biomedicines. 2022; 10(7):1480.
https://doi.org/10.3390/biomedicines10071480
Chicago/Turabian Style
Mena-Vázquez, Natalia, Marta Rojas-Gimenez, Clara Fuego-Varela, Aimara GarcÃa-Studer, Nair Perez-Gómez, Carmen MarÃa Romero-Barco, Francisco Javier Godoy-Navarrete, Sara Manrique-Arija, Myriam GandÃa-MartÃnez, Jerusalem Calvo-Gutiérrez,
and et al. 2022. "Safety and Effectiveness of Abatacept in a Prospective Cohort of Patients with Rheumatoid Arthritis–Associated Interstitial Lung Disease" Biomedicines 10, no. 7: 1480.
https://doi.org/10.3390/biomedicines10071480
APA Style
Mena-Vázquez, N., Rojas-Gimenez, M., Fuego-Varela, C., GarcÃa-Studer, A., Perez-Gómez, N., Romero-Barco, C. M., Godoy-Navarrete, F. J., Manrique-Arija, S., GandÃa-MartÃnez, M., Calvo-Gutiérrez, J., Morales-Garrido, P., Mouriño-Rodriguez, C., Castro-Pérez, P., Añón-Oñate, I., Espildora, F., Aguilar-Hurtado, M. C., Hidalgo Conde, A., Arnedo DÃez de los RÃos, R., Cabrera César, E.,
... Fernández-Nebro, A.
(2022). Safety and Effectiveness of Abatacept in a Prospective Cohort of Patients with Rheumatoid Arthritis–Associated Interstitial Lung Disease. Biomedicines, 10(7), 1480.
https://doi.org/10.3390/biomedicines10071480
